Bioactivity | P62-mediated mitophagy inducer (PMI) is a P62-mediated mitophagy activator. P62-mediated mitophagy inducer activates mitochondrial autophagy without recruitment of Parkin or collapse of the mitochondrial membrane potential and remains active in cells lacking a fully functional PINK1/Parkin pathway. P62-mediated mitophagy inducer serves as a pharmacological tool to study the molecular mechanisms of mitosis, avoiding toxicity and some of the non-specific effects associated with the sudden dissipation of mitochondria lacking membrane potential[1]. | |||||||||
Target | mitophagy. | |||||||||
Invitro | P62-mediated mitophagy inducer (10 µM; 0, 1, 3, 6, 24 h) stabilizes Nrf2 and (10 µM; 9 h) upregulates P62 expression activating mitophagy[1].P62-mediated mitophagy (10 µM; 24 h) acts downstream of the PINK1/Parkin signaling pathway in MEFs[1].P62-mediated mitophagy inducer positively affects mitochondrial poly-ubiquitination and coupling[1]. RT-PCR[1] Cell Line: | |||||||||
Name | P62-mediated mitophagy inducer | |||||||||
CAS | 1809031-84-2 | |||||||||
Formula | C14H9IN4O2 | |||||||||
Molar Mass | 392.15 | |||||||||
Appearance | Solid | |||||||||
Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
Storage |
|
|||||||||
Reference | [1]. East DA, et al. PMI: a ΔΨm independent pharmacological regulator of mitophagy. Chem Biol. 2014 Nov 20;21(11):1585-96. |